Search - tctmd.com

Displaying 141 - 160 of 586

Sort: Relevancy | Date

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Miha Cercek

September 16, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Eli I. Lev, Uri Rosenschein

September 16, 2014

Presentation TCT 2014

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Miha Cercek

September 16, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Marko Noc

September 16, 2014

Presentation TCT 2014

Case #1: CTO in the Setting of ACS

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Aggeliki-Despoina F. Mavrogianni

September 16, 2014

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation TCT 2014

Real world comparison of MGuard stent versus bare metal stent for ST elevation myocardial infartion

Presenter: Agust?n Fernandez-Cisnal

September 16, 2014

Presentation TCT 2014

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

Presenter: Donghun Shin

September 16, 2014

Presentation TCT 2014

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Presenter: Yeo-Jeong Song

September 16, 2014

Presentation TCT 2014

Management of very elderly patients with ST elevation myocardial infarction

Presenter: Usha Rao

September 16, 2014

Presentation TCT 2014

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Presenter: Krishnankutty Sudhir

September 16, 2014

Presentation TCT 2014

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Presenter: Carlo Di Mario

September 16, 2014

Presentation TCT 2014

Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-segment Elevation

Presenter: Josephine Warren

September 16, 2014

Presentation TCT 2014

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Presenter: Alok Saurav

September 16, 2014

Presentation TCT 2014

Impact of Hospital vs_ Home call for Fellows and Cath Lab Team on Door to Balloon Times

Presenter: Luke Kohan

September 16, 2014

Presentation TCT 2014

Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention

Presenter: Ahmed Rehmani

September 16, 2014

Presentation TCT 2014

Gender-related Differences in 30-day Mortality Among Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Angioplasty

Presenter: Francesco Tomassini

September 16, 2014

Presentation TCT 2014

Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___

Presenter: Marije L?wik

September 16, 2014

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Acute Left Ventricular Unloading and Delayed Coronary Reperfusion Promotes Stromal Cell Derived Factor-1 (SDF-1) Expression and Cardioprotective Signaling in Acute Myocardial___

Presenter: Navin Kapur

September 16, 2014

Advertisement

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

How Would I Treat This Patient?

Case #1: CTO in the Setting of ACS

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Real world comparison of MGuard stent versus bare metal stent for ST elevation myocardial infartion

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Management of very elderly patients with ST elevation myocardial infarction

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-segment Elevation

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Impact of Hospital vs_ Home call for Fellows and Cath Lab Team on Door to Balloon Times

Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention

Gender-related Differences in 30-day Mortality Among Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Angioplasty

Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Acute Left Ventricular Unloading and Delayed Coronary Reperfusion Promotes Stromal Cell Derived Factor-1 (SDF-1) Expression and Cardioprotective Signaling in Acute Myocardial___

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content